Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp179 | Benign Thyroid Disorders | ECE2019

Long-term cardiometabolic effects of maternal sub-optimal gestational thyroid function and relative treatment in the Controlled Antenatal Thyroid Screening (CATS) study II

Muller Ilaria , Taylor Peter , Daniel Rhian , Hales Charlotte , Scholz Anna , Yin Xiaochen , Candler Toby , Pettit Rebecca , Evans William , Shillabeer Dionne , Draman Mohd , Dayan Colin , Tang Carolyn , Okosieme Onyebuchi , Gregory John , Lazarus John , Rees Aled , Ludgate Marian

Introduction: The effects of maternal suboptimal gestational thyroid function (SGTF) on age 3 offspring’s cognitive function were investigated in the Controlled Antenatal Thyroid Screening (CATS) randomised trial, comparing SGTF mothers who received (SGTF-T), or didn’t (SGTF-U), levothyroxine during pregnancy. The analysis was repeated at age 9 in the CATS-II follow-up study, also including children of mothers with normal gestational thyroid function (NGTF). Here we ...

ea0059p200 | Thyroid | SFEBES2018

Controlled Antenatal Thyroid Screening (CATS) II: long-term cardiometabolic effects of treating maternal sub-optimal thyroid function

Muller Ilaria , Daniel Rhian , Hales Charlotte , Scholz Anna , Yin Xiaochen , Candler Toby , Pettit Rebecca , Evans William , Taylor Peter , Shillabeer Dionne , Draman Mohd , Dayan Colin , Tang Carolyn , Okosieme Onyebuchi , Gregory John , Lazarus John , Rees Aled , Ludgate Marian

Objectives: The Controlled Antenatal Thyroid Screening (CATS) study I was a randomised trial investigating the effects of levothyroxine treatment for suboptimal gestational thyroid function (SGTF), evaluating mothers with normal gestational thyroid function (NGTF), SGTF who received (SGTF-T), or didn’t (SGTF-U), levothyroxine during pregnancy. The present follow-up study (CATS II) reports the long-term effects of SGTF and levothyroxine treatment on anthropometric and card...

ea0037s21.2 | Thyroid hormone in pregnancy | ECE2015

Consequences of maternal thyroid dysfunction for offspring

Lazarus John

Treatment of hyperthyroidism with antithyroid drugs has recently been shown to have an effect on MMI/Carbimazole embryopathy at a specific early window in gestation. This has important implications for management.There is agreement that untreated overt gestational hypothyroidism is associated with significant adverse obstetric and fetal/neonatal effects. Although there is also substantial evidence that gestational subclinical hypothyroidism (SCH) is asso...

ea0034oc1.1 | Young Endocrinologists prize session | SFEBES2014

The Thr92Ala substitution in deiodonase-2 is associated with increased odds of a sub-optimal IQ score in children with low-normal thyroid function

Taylor Peter , Okosieme Onyebuchi , Sayers Adrian , Northstone Kate , Draman Mohd , Stevenson Kirsty , Woltersdorf Wolf , Taylor Andrew , Pearce Elizabeth , Panicker Vijay , Ludgate Marian , Gregory John , Lazarus John , Timpson Nicholas , Channon Sue , Dayan Colin

Importance: Thyroid hormone is essential for cognitive development. The Thr92Ala substitution in deiodonase-2 appears to reduce intracellular availability of active thyroid hormone. Individuals with low-normal serum thyroid hormone levels and this substitution might have insufficient intracellular thyroid hormone for optimal cognitive development.Objective: To explore whether individuals with low thyroid hormone bioavailability – free thyroxine in t...

ea0013p303 | Thyroid | SFEBES2007

W546X mutation of the thyrotropin receptor, cause of subclinical hypothyroidism (SH) in various clinical settings

Locantore Pietro , Evans Carol , Zhang Lei , Warner Justin , Gregory John , John Rhys , Lazarus John , Ludgate Marian

Objectives: Pregnancy and early infancy are periods when increased demand for thyroid hormone can result in subclinical hypothyroidism (SH). SH is frequently a prodrome to autoimmunity, but may be a compensation mechanism for an underlying genetic defect. The W546X mutation of the thyrotropin receptor (TSHR) is present at a frequency of 1 in 180 in a Caucasian population. We aimed to investigate whether W546X was the cause of SH presenting in pregnancy and early infancy.<p...

ea0013p321 | Thyroid | SFEBES2007

Central arterial stiffness in resistance to thyroid hormone

Owen Penelope , John Rhys , Mitchell Catherine , Curran Suzanne , Chatterjee Krishna , Lazarus John

Resistance to thyroid hormone (RTH) is a rare, autosomal dominant disorder characterised by a reduced sensitivity of peripheral tissues to thyroid hormone. Thyroid function testing shows elevation of free T4 and T3 with non suppressed TSH levels.Vascular function in these patients has not been fully evaluated. We have studied central arterial stiffness in a cohort of RTH patients, comparing them with age and sex matched controls.Me...

ea0077oc6.5 | Thyroid | SFEBES2021

Effects of in utero thyroid hormone exposure on human neurodevelopment: MRI analysis from the Controlled Antenatal Thyroid Screening Study

Scholz Anna , Bloomfield Laura , Chambers Mari , Bhargava Raghav , Taylor Peter , Ludgate Marion , Lazarus John H , Jones Derek , Rees Aled

Background: The Controlled Antenatal Thyroid Screening II (CATS) study, a large randomised trial of thyroxine supplementation for suboptimal gestational thyroid function (SGTF), reported a higher prevalence of elevated attention deficit hyperactivity disorder (ADHD) scores in 9 year-old children exposed to higher thyroid hormone (TH) in utero. Here we investigated if this was accompanied by altered neurodevelopment.Methods: 85 children aged 11-1...

ea0013p224 | AMEND Young Investigator's Award | SFEBES2007

Clinical impact of thyroglobulin epitope recognition pattern in patients with differentiated thyroid carcinoma and positive thyroglobulin antibodies

Lupoli Gelsy A , Okosieme Onyebuchi E , Evans Carol , Parkes Arthur B , Ruf Jean , Poggiano Maria R , Lupoli Giovanni , Lazarus John H

Background: Serum thyroglobulin (Tg) is a useful marker of recurrent or persistent disease in the follow-up of patients with differentiated thyroid carcinoma (DTC); the presence of interfering Tg antibodies (TgAb), even in low concentrations, can lead to a distorted evaluation of this marker. However, TgAb by itself has been shown to be a marker of disease following surgery. TgAb recognition of Tg epitopes differs in pathological and non-pathological states and may thus have p...

ea0094p127 | Thyroid | SFEBES2023

Effects of in utero thyroid hormone exposure on adolescent myelination: Quantitative magnetization transfer imaging in the controlled antenatal thyroid screening study

Scholz Anna , McNabb Carolyn , Bloomfield Laura , Bhargava Raghav , Taylor Peter , Lazarus John , Ludgate Marian , Jones Derek , Rees Aled

Introduction: The Controlled Antenatal Thyroid Screening II (CATS) study, a large randomised trial of thyroxine supplementation for suboptimal gestational thyroid function (SGTF), reported higher attention deficit hyperactivity disorder (ADHD) scores in 9 year-old children exposed to higher thyroid hormone (TH) in utero. We investigated if this was accompanied by altered myelination.Methods: Eighty-five children...

ea0044oc3.3 | Thyroid and Neoplasia | SFEBES2016

Post-Radioiodine Graves’ Management: The Pragma-Study

Perros Petros , Dayan Colin , Vaidya Bijay , Williams Graham , Lazarus John H , Hickey Janis , Willis Debbie , Archer Natasha , Franklyn Jayne , Basu Ansu

Introduction: Radioiodine (RI) is a safe and effective treatment for Graves’ disease. In the months following RI different strategies are used to gain control of thyroid status, although there is no evidence base as to the optimal approach.Objectives: To compare the incidence of dysthyroidism post-RI between three principal management strategies employed by clinicians.Study design and methods: Retrospective, observational, mul...